Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of T cells by antigen, lectin, or a combination of phorbol-12-myristate acetate (PMA) and calcium ionophore (A23187) leads to the induction of genes for a set of lymphokines, including
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
). We demonstrated in earlier studies that the upstream region of the mouse
GM-CSF
promoter at positions between -95 and -73 is essential for transcriptional activation in response to PMA/A23187. This region contains two DNA-binding motifs,
GM2
and GC-box. The
GM2
sequence (GGTAGTTCCC) is recognized by an inducible factor NF-
GM2
; the other (CCGCCC) by constitutive factors A1, A2, and B. To elucidate the mechanism of
GM-CSF
gene activation, we have purified the inducible factor NF-
GM2
from the nuclear extract of stimulated Jurkat cells on the basis of specific DNA-binding activity. The purified NF-
GM2
consists of 50 (p50) and 65 kDa (p65) polypeptides and has a binding activity specific for both the
GM-CSF
and immunoglobulin kappa (GGAAAGTCCC) enhancers. Electrophoretically purified p50 alone can form a protein-DNA complex, but in the mixture, p50 associates preferentially with p65 to form the NF-
GM2
complex. In addition, p65 gave per se, with low affinity, a protein-DNA complex that migrated more slowly than native NF-
GM2
complex. Furthermore, an antiserum against KBF1 (identical to 50 kDa NF-kappa B protein) reacted with the p50 of NF-
GM2
, indicating that the NF-
GM2
polypeptide cannot be immunologically differentiated from the 50 kDa subunit of NF-kappa B. The purified NF-
GM2
activated in vitro transcription from the kappa B enhancer, while it failed to stimulate transcription from the
GM-CSF
promoter harboring the
GM2
sequence. This suggests that the activation mechanism of the
GM-CSF
gene through the
GM2
/GC-box sequence is different from that of genes carrying the kappa B enhancer alone.
...
PMID:A nuclear factor NF-GM2 that interacts with a regulatory region of the GM-CSF gene essential for its induction in responses to T-cell activation: purification from human T-cell leukemia line Jurkat cells and similarity to NF-kappa B. 191 48